Birdwatch Note Rating
2023-03-16 12:57:20 UTC - HELPFUL
Rated by Participant: 7C4324436340F84C86C294D41C9DEB2D637D884E0B85B91035792B46FB056002
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details